News about Global Pharma

CordenPharma and Pivot Energy Partners to Propel Renewable Energy Initiatives

CordenPharma and Pivot Energy Partners to Propel Renewable Energy Initiatives

Under the terms of the agreement, CordenPharma Colorado will tap into renewable energy generated by solar installations owned and operated by Pivot Energy.

Global Pharma | 16/02/2024 | By Manvi

AMO Pharma Announces Collaboration with Population Health Research Institute to Advance Proof of Concept Clinical Trial

AMO Pharma Announces Collaboration with Population Health Research Institute to Advance Proof of Concept Clinical Trial

AMO Pharma's investigational oral glycogen synthase kinase 3 beta (GSK3β) inhibitor, in the treatment of genotype positive arrhythmogenic cardiomyopathy (ACM).

Global Pharma | 15/02/2024 | By Manvi

Citius Pharmaceuticals Resubmits the Biologics License Application of LYMPHIR for Treatment of Adults

Citius Pharmaceuticals Resubmits the Biologics License Application of LYMPHIR for Treatment of Adults

Citius believes it has addressed enhanced product testing and additional manufacturing controls noted in the letter. There were no safety or efficacy issues cited and no additional trials required.

Global Pharma | 14/02/2024 | By Manvi

Chanelle Pharma Acquired by Exponent, Marking a New Era

Chanelle Pharma Acquired by Exponent, Marking a New Era

With over 730 employees across various locations, the company has established a strong foothold in Ireland, the UK, Europe, and Jordan.

Global Pharma | 14/02/2024 | By Manvi 220

Aurobindo Pharma Granted USFDA Approval for Deflazacort Tablets

Aurobindo Pharma Granted USFDA Approval for Deflazacort Tablets

The company plans to launch the product in February 2024.

Global Pharma | 14/02/2024 | By Manvi

Alys Pharmaceuticals Launches with USD 100 Million Financing to Redefine Immuno-Dermatology Landscape

Alys Pharmaceuticals Launches with USD 100 Million Financing to Redefine Immuno-Dermatology Landscape

Born from the amalgamation of six asset-centric Medicxi companies, Alys aims to revolutionize dermatological treatments with its innovative programs and platforms targeting various dermatological indications.

Global Pharma | 13/02/2024 | By Manvi

Aparna Organics Receives USFDA VAI Classification for Manufacturing Facility

Aparna Organics Receives USFDA VAI Classification for Manufacturing Facility

Its manufacturing facility, Aparna Organics, located in Pydibhimavaram, Srikakulam, Andhra Pradesh, has been awarded the VAI classification by the USFDA.

Global Pharma | 13/02/2024 | By Manvi

Lykos Therapeutics Announces FDA Acceptance

Lykos Therapeutics Announces FDA Acceptance

The FDA has granted the application priority review and has assigned a Prescription Drug User Fee Act (PDUFA) target action date of August 11, 2024.

Global Pharma | 10/02/2024 | By Manvi

Zynex Receives FDA Clearance for Next-Gen M-Wave Neuromuscular Stimulation Device

Zynex Receives FDA Clearance for Next-Gen M-Wave Neuromuscular Stimulation Device

The M-Wave, successor to the renowned E-Wave, revolutionizes NMES treatments with enhanced functionality and a user-friendly design.

Global Pharma | 08/02/2024 | By Manvi 151

Sibel Health's ANNE One Receives 4th FDA Clearance for Continuous Wearable Vital Signs Monitoring

Sibel Health's ANNE One Receives 4th FDA Clearance for Continuous Wearable Vital Signs Monitoring

This latest clearance expands the capabilities of the ANNE® One platform to include continuous ambulatory ECG monitoring, SpO2, temperature, and non-invasive blood pressure measurements.

Global Pharma | 08/02/2024 | By Manvi

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members